Patent 7414071 was granted and assigned to Pfizer on August, 2008 by the United States Patent and Trademark Office.
The present invention provides a method of treating hypertension, liver failure, loss of patency of ductus arteriosus, glaucoma or ocular hypertension in a patient, comprising administering to the patient a therapeutically effective amount of a selective EP4 receptor agonist of Formula I